"Oncologic Outcomes of Robotic Left Pancreatectomy for Pancreatic Adeno" by Maria Baimas-George, Michael Watson et al.
 

Oncologic Outcomes of Robotic Left Pancreatectomy for Pancreatic Adenocarcinoma: A Single-Center Comparison to Laparoscopic Resection.

Publication/Presentation Date

1-1-2021

Abstract

BACKGROUND: Feasibility and safety of robotic surgery for pancreatic disease has been well demonstrated; however, there is scarce literature on long-term oncologic outcomes. We compared perioperative and oncologic outcomes between robotic left pancreatectomy (RLP) and laparoscopic left pancreatectomy (LLP) for pancreatic adenocarcinoma.

METHODS: A retrospective review evaluated left pancreatectomies performed for pancreatic adenocarcinoma from 2009 to 2019 in a tertiary institution. Baseline characteristics, operative and oncologic outcomes were compared between RLP and LLP.

RESULTS: There were 75 minimally invasive left pancreatectomy cases for pancreatic adenocarcinoma identified of which 33 cases were done robotically and 42 laparoscopically. Baseline characteristics demonstrated no difference in gender, age, BMI, T stage, N stage, neoadjuvant, or adjuvant chemotherapy. An analysis of operative variables demonstrated no difference in blood loss, increased duration, and higher lymph node yield with RLP (20 vs 12;

CONCLUSION: This analysis demonstrates RLP is at least equivalent to LLP in perioperative and oncologic outcomes. The significantly higher lymph node yield and trend toward an improved survival suggests oncologic advantage. Randomized controlled studies are needed to clarify benefit.

Volume

87

Issue

1

First Page

45

Last Page

49

ISSN

1555-9823

Disciplines

Medicine and Health Sciences

PubMedID

32915060

Department(s)

Department of Surgery, Lehigh Valley Topper Cancer Institute

Document Type

Article

Share

COinS